(Q38602671)

4 September 2017

Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101 (English)

1 reference

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

21 March 2024

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

21 March 2024

9

P Fishman

1 reference

4 September 2017

G. Ohana

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

S. Bar-Yehuda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

A. Arich

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

L. Madi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

Z. Dreznick

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

L. Rath-Wolfson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

D. Silberman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

G. Slosman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 September 2017

20 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14562031

full work available at URL

21 March 2024

https://www.nature.com/articles/6601315.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

https://europepmc.org/articles/PMC2394357

21 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

https://europepmc.org/articles/PMC2394357?pdf=render

21 March 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

http://www.nature.com/articles/6601315.pdf

21 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

http://www.nature.com/articles/6601315

21 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

British Journal of Cancer

21 March 2024

published in

1 reference

4 September 2017

89

1 reference

4 September 2017

8

1 reference

4 September 2017

1552-1558

1 reference

The biology of natural killer cells in cancer, infection, and pregnancy

4 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Resistance of muscle to tumor metastases: a role for a3 adenosine receptor agonists

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Adenosine A3 receptor stimulation and cerebral ischemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Structure and function of A1 adenosine receptors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

The regulation and biological activity of interleukin 12.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Interleukin-12 and its role in the generation of TH1 cells

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Stages of intestinal carcinogenesis and their control by host NK cells. Implications to prevention and therapy.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Muscle cells produce a low molecular weight factor with anti-cancer activity

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

The A3 adenosine receptor as a new target for cancer therapy and chemoprotection

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

A3-adenosine receptors: design of selective ligands and therapeutic prospects

31 August 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601315

Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors

21 January 2018

1 reference

12 December 2020

The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent

1 reference

12 December 2020

Interleukin-3 and granulocyte colony-stimulating factor as survival factors in murine hemopoietic stem cells in vitro

1 reference

12 December 2020

Adenosine receptors and beyond: molecular mechanisms of physiological regulation

1 reference

12 December 2020

Synergistic factors for stem cell proliferation: further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor

1 reference

12 December 2020

Modulation of human natural killer cell activity by pharmacological mediators

1 reference

12 December 2020

Synergistic effect of granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on neutrophil production in mice

1 reference

12 December 2020

Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart

1 reference

12 December 2020

Elevation of extracellular adenosine induces radioprotective effects in mice

1 reference

12 December 2020

United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition)

1 reference

12 December 2020

Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine synergize to enhance haematopoietic reconstitution in irradiated mice

1 reference

12 December 2020

An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice

1 reference

12 December 2020

Cellular and Molecular Biology

5

43

345

TL Bowlin

1997

1 reference

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

21 March 2024

27

38

10

G Stiles

1990

1 reference

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

British Journal of Cancer

21 March 2024

30

77

1

P Workman

1998

1 reference

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

21 March 2024

Identifiers

1 reference

Dimensions Publication ID

4 September 2017

0 references

1 reference

4 September 2017

1 reference